Femasys Inc.

FEMY Healthcare Medical Instruments & Supplies

Femasys Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 million, up 40.8% from fiscal 2024. In the quarter to June 2026, revenue fell 18.9%, EPS grew 58.4%, free cash flow grew 11.3% and total debt rose 3,369.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.65 0.09 −5.17%
Market cap
$14.5M
P/E
0.0×
Fwd P/E
−1.4×
Dividend yield
—
F-score
2/9
Altman Z
−10.88
Beneish M
−2.19
Dividend safety
n/a
Dec '17 Jan '19 Dec '19 Jan '20 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — — 3 2 2 3 2
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — — — — 3.03 (5.24) (5.33) (17.50) (10.88)
P/S ratio
— 10.79 10.79 10.79 10.79 22.19 8.82 14.49 15.04 9.93
Altman Z″-Score (non-manufacturers)
— (27.29) (27.29) (44.56) (38.43) 6.42 (8.20) (9.44) (42.98) (24.17)
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
— (10.30) (10.30) (10.30) (10.30) (11.64) (3.71) (5.12) (4.83) (5.44)
Beneish M-Score
— — — — (3.71) (2.77) (2.66) (3.08) 0.20 (2.19)
P/B ratio
— 0.00 0.00 0.00 0.00 0.99 0.70 0.85 10.63 3.88
EV/Sales
— 60.75 60.75 60.75 60.75 1.32 (1.81) (1.68) 13.00 8.20
EV/EBITDA
— 0.00 0.00 0.00 0.00 0.00 0.20 0.13 0.00 0.00
EV/FCF
— (11.04) (11.04) (11.04) (11.04) (0.19) 0.20 0.16 (1.05) (0.98)
Current Ratio
— 6.25 6.25 1.34 1.34 15.15 9.25 7.59 0.93 4.53
Net Debt/EBITDA
— (4.71) (4.71) (9.27) 0.31 3.18 1.16 1.24 0.19 0.23
Debt/Equity
— (1.26) (1.26) (1.11) (0.03) 0.01 0.01 0.24 0.06 0.90
ROE
— 24.83% 24.83% 14.23% 13.34% 59.12% (54.81%) (84.82%) (182.18%) (455.80%)
ROA
— (178.27%) (89.13%) (68.29%) (90.91%) (41.66%) (50.11%) (63.81%) (93.61%) (112.32%)
ROIC
— 0.00% 0.00% 0.00% 0.00% (303.27%) (299.29%) (893.46%) 0.00% (578.36%)
Return on Tangible Assets
— (106.18%) (106.18%) (179.15%) (246.75%) (29.52%) (80.89%) (67.09%) (1,816.80%) (126.59%)
Average Days of Receivables
— 32.84 32.84 44.24 44.24 26.08 23.45 33.67 109.43 98.14
Earnings Yield
— (42.02%) (42.02%) (42.02%) (42.02%) (67.42%) (105.56%) (91.09%) (77.27%) (86.81%)
Free Cash Flow Yield
— (50.98%) (50.98%) (50.98%) (50.98%) (31.47%) (104.75%) (73.53%) (82.49%) (84.35%)
Free Cash Flow per Share
— 0.00 (0.94) 0.00 (103.43) (24.55) (18.85) (14.85) (18.15) (9.72)
Book value per Share
— 0.00 (3.86) 0.00 (1,079.49) 78.46 25.80 23.86 2.07 2.97
Free Cash Flow
— (10.55) (11.01) (4.49) (4.96) (8.24) (11.14) (11.42) (20.21) (19.22)
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.19 0.12 0.00 0.00
Other line items

Show all line items

Columns are period end dates